Use of paracetamol in the treatment of dengue and liver damage: review

Authors

  • Maria Jucileide dos Santos Pinheiro University Center of Southwest Goiano, UniBRAS, Rio Verde, Goiás, Brazil
  • Jacqueline da Silva Guimarães dos Santos University Center of Southwest Goiano, UniBRAS, Rio Verde, Goiás, Brazil
  • Luciana Arantes Dantas University Center of Southwest Goiano, UniBRAS, Rio Verde, Goiás, Brazil

DOI:

https://doi.org/10.14295/bjs.v2i4.279

Keywords:

dengue virus, flavivirus, hemorrhages, Aedes aegypti

Abstract

Dengue is a viral disease that, especially in South America, has become a considerable public health problem. Depending on the severity, liver damage at various levels of impairment can be among the different effects of that disease. Fever, headache, and body pain in people with dengue are symptoms for which health agencies recommend analgesic medications. Acetaminophen is a drug that, depending on the dosage, can affect the human liver organ. Considering this, the objective of this study is to present a relationship between acetaminophen, dengue and liver problems that can be triggered by the medication. It appears that a large part of the studies still don´t consider alternatives for the use of existing drugs. These are studies that still reinforce that acetaminophen, even in the face of possible damage, is a considerable option for relieving dengue symptoms. From the study, it was possible to understand the risks of using other drugs for dengue symptoms, as well as the effective action of the population and the government in preventing the disease, through campaigns and public policies.

References

Anvisa (2010). Farmacopeia Brasileira. 5ª edição. Brasília: Anvisa.

Biassoti, A. V., Ortiz, M. A. L. (2017). Diagnóstico laboratorial da dengue. Rev UNINGÁ Review. 29(1), 122-126.

Bhatt, S., Gething, P. W., Brady, O. J., Messina, J. P., Farlow, A. W., & Moyes, C. L. (2013). The global distribution and burden of dengue. Nature, 496(7446), 504-507. https://doi.org/10.1038%2Fnature12060 DOI: https://doi.org/10.1038/nature12060

Bomfim, M., Lima, C. C., Jucimara, M., Rosângela, C. (2022). Intoxicação por paracetamol com análise de mitos e verdades: uma revisão da literatura. Monografia (Graduação em Farmácia) - Centro Universitário AGES, Paripiranga.

Brayner, N. F., da Silva, A. A., & de Almeida, F. R. (2018). O risco do uso irracional do paracetamol na população brasileira e seus efeitos na hemostasia. Revista Rios, 12(16), 138-153.

Brasil (2013). Ministério da Saúde. Secretaria de Vigilância em Saúde. Diretoria Técnica de Gestão. Dengue: diagnóstico e manejo clínico: adulto e criança. 4. ed. Brasília: Ministério da Saúde.

Carrington, L. B., & Simmons, C. P. (2014). Human to mosquito transmission of dengue viruses. Frontiers in immunology, 5, 290. https://doi.org/10.3389/fimmu.2014.00290 DOI: https://doi.org/10.3389/fimmu.2014.00290

Cesar, V. M., Piloto, J. A. R. (2015). Hepatotoxicidade do paracetamol empacientes com dengue. Brazilian Journal of Surgery and Clinical Research, 9(1), 91-98.

Céspedes, M., Gutiérrez, S., Torrico, A., & Paz, F. (2018). Efectos de la administración de dipirona en niños tratados por dengue con signos de alarma. Arch Pediatr Urug, 89(2), 140-6.

Dantas, R. (2013). Hepatotoxidade do paracetamol em pacientes com dengue. Monografia (Graduação em Medicina) - Faculdade de Medicina da Bahia, Universidade Federal da Bahia, Salvador.

Deen, J., & von Seidlein, L. (2019). Paracetamol for dengue fever: no benefit and potential harm?. The Lancet Global Health, 7(5), e552-e553. https://doi.org/10.1016/S2214-109X(19)30157-3 DOI: https://doi.org/10.1016/S2214-109X(19)30157-3

Dissanayake, D. M. D. I. B., Gunaratne, W. M. S. N., Kumarihamy, K. W. M. P. P., Kularatne, S. A. M., & Kumarasiri, P. V. R. (2021). Use of intravenous N-acetylcysteine in acute severe hepatitis due to severe dengue infection: a case series. BMC Infectious Diseases, 21(1), 1-8. https://doi.org/10.1186/s12879-021-06681-9 DOI: https://doi.org/10.1186/s12879-021-06681-9

Dissanayake, H. A., Seneviratne, S. L. (2018). Liver involvement in dengue viral infections. Reviews in medical virology, 28(2), e1971. https://doi.org/10.1002/rmv.1971 DOI: https://doi.org/10.1002/rmv.1971

Ferreira, R. A. X., Kubelka, C. F., Velarde, L. G. C., Matos, J. P. S. D., Ferreira, L. C., Reid, M. M., ... & Oliveira, S. A. D. (2018). Predictive factors of dengue severity in hospitalized children and adolescents in Rio de Janeiro, Brazil. Revista da Sociedade Brasileira de Medicina Tropical, 51(6), 753-760. https://doi.org/10.1590/0037-8682-0036-2018 DOI: https://doi.org/10.1590/0037-8682-0036-2018

Ferreira, J. G. G. (2019). Avaliação das assinaturas de expressão gênica em hepatócitos AML-12 após infecção pelo Dengue virus e tratamento com Acetaminofen. Tese (Doutorado em Ciências da Saúde) - Instituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte.

Ferreira, J. G., Gava, S. G., Oliveira, E. S., Batista, I. C., Fernandes, G. D. R., Mourão, M. M., & Calzavara-Silva, C. E. (2020). Gene expression signatures in AML-12 hepatocyte cells upon Dengue virus infection and acetaminophen treatment. Viruses, 12(11), 1284. https://doi.org/10.3390/v12111284 DOI: https://doi.org/10.3390/v12111284

Filha, L. G. F., & de Paula, A. M. (2019). Evolução da dengue no mundo. Revista Gestão & Tecnologia, 1(28), 33-50.

Guimarães, F. D. P. G., de Souza Júnior, E. C., Júnior, C. A. M., & Nascimento, J. W. L. (2021). Política de proibição da dipirona: uma reflexão. Brazilian Journal of Health Review, 4(3), 11007-11019. https://doi.org/10.34119/bjhrv4n3-109 DOI: https://doi.org/10.34119/bjhrv4n3-109

Gutiérrez-Lesmes, O. A., Plata-Casas, L. I., & Montaño-Contreras, S. C. (2016). Mortalidad en pacientes menores de edad con diagnóstico de dengue y su relación con el uso de Dipirona. Universidad y Salud, 18(3), 550-555. DOI: https://doi.org/10.22267/rus.161803.60

Guyton, A. C., Hall, J. E. (2017). Tratado de Fisiologia Médica. 13. ed. São Paulo: Editora Elsevier.

Heinz, F. X., & Stiasny, K. (2012). Flaviviruses and their antigenic structure. Journal of Clinical Virology, 55(4), 289-295. https://doi.org/10.1016/j.jcv.2012.08.024 DOI: https://doi.org/10.1016/j.jcv.2012.08.024

Hoefler, R. (2015). Uso do paracetamol em pacientes com dengue. Farmacoterapêutica, 19(2), 3-9.

Jácome, F. C. (2021). Estudos do tropismo de duas linhagens do vírus dengue tipo 2 em modelo experimental murino: análises clínicas, bioquímicas e morfológicas. Tese (Doutorado em Medicina Tropical) - Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro.

Lima, J. E. N., Gonçalves, L. L., Moreira, R. C. D., Cavalcante, N. S. R. (2016). O uso de AINEs no tratamento de doenças tropicais virais no Brasil. In: Congresso Brasileiro de Ciências da Saúde, Anais, I CONBRACIS

Melo, C. F. O. R., Delafiori, J., Dabaja, M. Z., de Oliveira, D. N., Guerreiro, T. M., Colombo, T. E., ... & Catharino, R. R. (2018). The role of lipids in the inception, maintenance and complications of dengue virus infection. Scientific reports, 8(1), 1-9. https://doi.org/10.1038/s41598-018-30385-x DOI: https://doi.org/10.1038/s41598-018-30385-x

Morais, A. A. F. de. Manual de trabalhos acadêmicos do IESRIVER. Rio Verde: Instituto de Ensino Superior de Rio Verde, 2018.

Murray, N. E. A., Quam, M. B., & Wilder-Smith, A. (2013). Epidemiology of dengue: past, present and future prospects. Clinical epidemiology, 5, 299-309. http://dx.doi.org/10.2147/CLEP.S34440 DOI: https://doi.org/10.2147/CLEP.S34440

Mustafa, M. S., Rasotgi, V., Jain, S., & Gupta, V. J. M. J. A. F. I. (2015). Discovery of fifth serotype of dengue virus (DENV-5): A new public health dilemma in dengue control. Medical journal armed forces India, 71(1), 67-70. https://doi.org/10.1016/j.mjafi.2014.09.011 DOI: https://doi.org/10.1016/j.mjafi.2014.09.011

Ornelas, A. M. D. M., Xavier-de-Carvalho, C., Alvarado-Arnez, L. E., Ribeiro-Alves, M., Rossi, Á. D., Tanuri, A., ... & Cardoso, C. C. (2019). Association between MBL2 haplotypes and dengue severity in children from Rio de Janeiro, Brazil. Memórias do Instituto Oswaldo Cruz, 114. https://doi.org/10.1590/0074-02760190004 DOI: https://doi.org/10.1590/0074-02760190004

Paranavitane, S. A., Gomes, L., Kamaladasa, A., Adikari, T. N., Wickramasinghe, N., Jeewandara, C., ... & Malavige, G. N. (2014). Dengue NS1 antigen as a marker of severe clinical disease. BMC infectious diseases, 14(1), 1-7. https://doi.org/10.1186/s12879-014-0570-8 DOI: https://doi.org/10.1186/s12879-014-0570-8

Riane, K., Ouled-Haddar, H., Alyane, M., Sifour, M., Espinosa, C., & Esteban, M. A. (2019). Assessment of Streptococcus salivarius sp thermophiles Antioxidant Efficiency and its Role in Reducing Paracetamol Hepatotoxicity. Iranian Journal of Biotechnology, 17(4), e2061. https://doi.org/10.30498%2FIJB.2019.91761

Roy, S. K., & Bhattacharjee, S. (2021). Dengue virus: epidemiology, biology, and disease aetiology. Canadian Journal of Microbiology, 67(10), 687-702. https://doi.org/10.1139/cjm-2020-0572 DOI: https://doi.org/10.1139/cjm-2020-0572

Shepard, D. S., Undurraga, E. A., Halasa, Y. A., & Stanaway, J. D. (2016). The global economic burden of dengue: a systematic analysis. The Lancet infectious diseases, 16(8), 935-941. https://doi.org/10.1016/S1473-3099(16)00146-8 DOI: https://doi.org/10.1016/S1473-3099(16)00146-8

Simmonds, P., Becher, P., Bukh, J., Gould, E. A., Meyers, G., Monath, T., ... & Consortium, I. R. (2017). ICTV virus taxonomy profile: Flaviviridae. The Journal of general virology, 98(1), 2-3. https://doi.org/10.1099%2Fjgv.0.000672 DOI: https://doi.org/10.1099/jgv.0.000672

Tafere, G. G., Wondafrash, D. Z., & Demoz, F. B. (2020). Repurposing of N-Acetylcysteine for the Treatment of Dengue Virus-Induced Acute Liver Failure. Hepatic Medicine: Evidence and Research, 12, 173-178. https://doi.org/10.2147%2FHMER.S263840 DOI: https://doi.org/10.2147/HMER.S263840

Gonzales Trigoso, M. T., & Guzmán Valer, G. (2022). Factores asociados a la automedicación por dengue en usuarios de la Botica Santa Beatriz en la ciudad de Puerto Maldonado - 2022. Tesis (Titulo Profesional de Químico Farmacéutico) - Facultad de Ciencias de la Salud, Escuela Profesional de Ciencias Farmacéuticas y Bioquímica

Vasikasin, V., Rojdumrongrattana, T., Chuerboonchai, W., Siriwiwattana, T., Thongtaeparak, W., Niyasom, S., ... & Changpradub, D. (2019). Effect of standard dose paracetamol versus placebo as antipyretic therapy on liver injury in adult dengue infection: a multicentre randomised controlled trial. The Lancet Global health, 7(5), e664-e670. https://doi.org/10.1016/S2214-109X(19)30032-4 DOI: https://doi.org/10.1016/S2214-109X(19)30032-4

Xisto, M. F. (2019). Proteína recombinante ns1 de vírus dengue para diagnóstico. Disponível em: https://www.locus.ufv.br/bitstream/123456789/26736/1/texto%20completo.pdf. Acesso em: 15 set. 2022.

Wan, S. W., Wu-Hsieh, B. A., Lin, Y. S., Chen, W. Y., Huang, Y., & Anderson, R. (2018). The monocyte-macrophage-mast cell axis in dengue pathogenesis. Journal of biomedical science, 25(1), 1-10. https://doi.org/10.1186/s12929-018-0482-9 DOI: https://doi.org/10.1186/s12929-018-0482-9

Zanini, F., Pu, S. Y., Bekerman, E., Einav, S., & Quake, S. R. (2018). Single-cell transcriptional dynamics of flavivirus infection. Elife, 7, e32942. https://doi.org/10.7554/eLife.32942 DOI: https://doi.org/10.7554/eLife.32942

Published

2023-04-01

How to Cite

Pinheiro, M. J. dos S., Santos, J. da S. G. dos, & Dantas, L. A. (2023). Use of paracetamol in the treatment of dengue and liver damage: review. Brazilian Journal of Science, 2(4), 32–40. https://doi.org/10.14295/bjs.v2i4.279